NCT01009593 2012-09-10Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)AbbottPhase 3 Terminated1,035 enrolled
NCT01556815 2012-04-25Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular CarcinomaShandong Cancer Hospital and InstitutePhase 2 Unknown40 enrolled